|1.||Mansart, Arnaud: 3 articles (09/2006 - 08/2003)|
|2.||Bollaert, Pierre-Edouard: 2 articles (09/2006 - 08/2003)|
|3.||Levy, Bruno: 2 articles (07/2004 - 08/2003)|
|4.||Crooks, Peter A: 2 articles (10/2003 - 02/2003)|
|5.||Bence, Aimee K: 2 articles (10/2003 - 02/2003)|
|6.||Urano, J: 2 articles (04/2000 - 01/2000)|
|7.||Tamanoi, F: 2 articles (04/2000 - 01/2000)|
|8.||Yang, W: 2 articles (04/2000 - 01/2000)|
|9.||Wink, Michael: 1 article (12/2015)|
|10.||Nurcahyanti, Agustina D R: 1 article (12/2015)|
02/01/1999 - "In conclusion, in a rodent model of endotoxinic shock, the continuous infusion of L-canavanine, a selective iNOS inhibitor, improved the systemic hemodynamic parameters and the intracellular bio-energetic patterns estimated by in vivo 31P MRS. "
02/01/2001 - "Furthermore, PR500 was also diminished in response to potential protein-misfolding stresses caused by the heat shock and canavanine treatment. "
01/11/1996 - "L-Canavanine is a potential agent in the treatment of endotoxin shock."
03/20/1995 - "The steady-state level of the uvi15+ gene product of about 12 kDa was increased by heat shock and canavanine, an amino acid analog. "
07/15/1989 - "Heat shock (42-43 degrees C) and canavanine (200-400 micrograms/ml) were used to evoke the heat shock response in these cells. "
|2.||Septic Shock (Toxic Shock Syndrome)
05/01/1996 - "3. In conclusion, L-canavanine produced beneficial haemodynamic and metabolic effects and improved survival in rodent endotoxic shock. "
05/01/1997 - "In the present study, we evaluated the effects of L-canavanine, a selective iNOS inhibitor, in an animal model of septic shock, with a particular focus on tissue oxidative metabolism and organ functions. "
12/12/1994 - "L-canavanine restores blood pressure in a rat model of endotoxic shock."
03/01/2001 - "This study suggests that L-canavanine induces tissue hypoperfusion and ischemia with concomitant hypersecretion of ET-1 in dogs with endotoxic shock."
05/01/1996 - "The aim of this study was to evaluate the effects of L-canavanine, a potentially selective inhibitor of inducible nitric oxide synthase, in an animal model of septic shock. "
04/01/2001 - "Since the transgene is not expressed (or poorly expressed) at the restrictive condition (34 degrees C), mixed populations can be selected in which tumor suppressors or other inhibitory genes can be strongly induced upon changing the conditions (39 degrees C or the plant amino acid L-canavanine). "
01/01/1995 - "Such hypothesis is confirmed by our in vivo experiments, showing that the administration of the NOS inhibitor L-canavanine to endothelioma-bearing mice significantly reduced both the volume and the relapse time of the tumor."
06/01/1986 - "The reduction in tumor volume, expressed as the percentage of regression, was 22% in animals receiving canavanine, 3.0 g/kg daily for 5 days and 60% in the 3.0-g/kg-daily-for-9-days treatment group. "
06/01/1986 - "When the tumors reached a size of 500 to 1000 mm3, the rats received canavanine, 2.0 g/kg or 3.0 g/kg s.c. "
06/01/1986 - "Growth inhibition of a rat colon tumor by L-canavanine."
11/01/1972 - "The effects of canavanine and of arginine starvation on macromolecular synthesis in Chlamydomonas reinhardi."
05/01/2012 - "In this report, we evaluated, for the first time, the efficacy of arginine deprivation as anticancer therapy in three-dimensional (3D) cultures of human tumor cells, and propose a new combinatorial metabolic-chemo-radio-treatment regime based on arginine starvation, low doses of arginine natural analog canavanine and irradiation. "
05/01/2012 - "Single amino acid arginine starvation efficiently sensitizes cancer cells to canavanine treatment and irradiation."
02/01/2011 - "Our data suggest that the incorporation of canavanine into anticancer treatment schemes based on artificially created arginine starvation could be a novel strategy in tumor enzymochemotherapy."
12/01/1985 - "The lon::delta Tn10 mutations and a lon deletion retaining only the amino-terminal 25% of the gene did not affect the energy-dependent degradation of proteins during starvation and led to only a 40 to 60% reduction in the ATP-dependent degradation of canavanine-containing proteins and puromycyl peptides. "
03/01/1997 - "L-canavanine significantly increased urine output and reduced the severity of lactic acidosis. "
03/01/2001 - "The LPS-induced lactic acidosis and hypersecretion of ET-1 were aggravated after L-canavanine infusion. "
05/01/1996 - "In contrast to L-canavanine, nitro-L-arginine methyl ester increased blood pressure at the expense of a severe fall in cardiac index, while largely enhancing lactic acidosis. "
|2.||Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)
|3.||NG-Nitroarginine Methyl Ester (L-NAME)
|4.||Nitric Oxide Synthase (NO Synthase)
|6.||Adenosine Triphosphate (ATP)
|7.||arginine methyl ester
|8.||omega-N-Methylarginine (NG Monomethyl L Arginine)
|4.||Drug Therapy (Chemotherapy)